Probiotic, Prebiotic and Postbiotic Claims in Cosmetic Products
Microbiome claims such as probiotic, prebiotic, postbiotic and other related terms are becoming more and more popular in the beauty industry. But what does it really mean? How can a cosmetic company justify such claims? How are these products regulated in terms of their safety and quality standards?

EU REGULATION ON COSMETIC CLAIMS

As addressed in one of our previous posts, when making available a cosmetic product in the EU market, the product must comply with the definition of cosmetic product according to the European Regulation (EC) No 1223/2009. Moreover, every single claim made or implied by the product has to be compliant with the Commission Regulation (EU) No 655/2013, which lays down common criteria for the justification of claims in cosmetic products. This applies to all cosmetic product claims, irrespective of the medium or type of marketing tool used, the product’s claimed functions or its the target audience.

In order to help companies to comply with the Commission Regulation No 655/2013, in 2017, the European Commission has published a technical document. Besides providing a detailed description of the common criteria, this document also lays down the best practices to be followed in regard to the type of evidential support used for the justification of cosmetic claims, as well as for the application of the common criteria to “free from” and “hypoallergenic” claims.

Claims can be made in the form of texts, names, trademarks, pictures and figurative or other signs that convey, explicitly or implicitly, product characteristic or functions in the labelling, marketing and advertising media.

MICROBIOME RELATED TERMS AND DEFINITIONS

In 2018, at the 12th annual meeting of International Cooperation on Cosmetics Regulation (ICCR), the topic of cosmetics and the microbiome was discussed. Given that “technologies exploring the relationship between the human microbiome and healthy skin was an area of increasing interest”, the ICCR Steering Committee agreed to create a new Joint Working Group (JWG) on the topic “Microbiome as it relates to Cosmetics”. Early this year, the ICCR has published a report entitled “Microbiome and Cosmetics: Survey of Products, Ingredients, Terminologies and Regulatory Approaches”.

According to the ICCR, Probiotics are “live or dormant micro-organisms (e.g. Lactobacillus casei, Lactobacillus acidophillus, Nitrosomonas eutropha, etc.)” and Prebiotics are “nutrients for probiotics or natural skin microbiota (e.g. niacinamide, minerals, thermal water, vitamins, oligosaccharides, natural oils, etc.)”. Postbiotics are defined as “soluble factors (products or metabolic by-products) secreted by live bacteria or released after bacterial lysis (e.g. Bifida ferment lysate, Lactococcus ferment lysate, Bacillus coagulans ferment, etc.)”. If a product is ‘microbiome friendly’ or ‘microbiota-friendly’, it means that it does not interfere with the skin microbiome.

MICROBIOME CLAIMS IN COSMETIC PRODUCTS

Presently, there are no international guidelines on definitions or terminologies applicable to microbiome claims in cosmetic products.

The U.S. Food and Drug Administration (FDA) has expressed some concerns related with this type of cosmetics, specifically with the efficacy, safety and quality of these products. There are still some outstanding questions raised by the FDA, like whether probiotics are still alive in cosmetics in the presence of preservatives or if they affect product quality and safety.

The definition of cosmetic product and the substance/mixture it contains does not make any reference to the terms ‘viable’ or ‘non-viable’, so it is not clear if prebiotics, probiotics and other fall into this definition. There is a regulatory uncertainty, as these ‘ingredients’ are neither explicitly banned or allowed.

In the European Union, the safety of a cosmetic product must be demonstrated and data on microbiological quality must be included in the Cosmetic Product Safety Report (CPSR), which is part of the Product Information File (PIF). The total count of aerobic mesophilic microorganisms (bacteria, yeasts and moulds) and the absence of specific microorganisms (Candida albicansStaphylococcus aureusPseudomonas aeruginosaEscherichia coli) should be included. Other regulated markets can establish different cosmetic requirements which may differ when it comes to the product’s microbiological quality standards.

For example, in South Korea, the use of live microorganisms in cosmetic products is usually not permitted. In Japan, “ingredients of cosmetics, including any impurities contained therein, shall not contain anything that may cause infection or that otherwise makes the use of the cosmetic a potential health hazard“. In Canada and USA, cosmetic products must comply with imposed microbiological limits. Depending on where the product shall be made available, the use of probiotics may not be a choice (as they are considered ‘live or dormant’ microrganisms) or it must comply with regional microbiological limits.

On another perspective, if a cosmetic product mentions it has pharmaceutical or medicinal-type activities, it will fall outside the cosmetic product definition set by the European Cosmetic Regulation. Claims like ‘microbiome-friendly’ usually fall under this definition. Therapeutic claims (e.g. preventing or treating diseases) are not permitted in cosmetics.

All cosmetic and personal care product must be proved as safe for the consumer, under normal and foreseeable conditions of use, and cosmetic claims must be supported and properly substantiated. However, some claims might be difficult or too complex to verify or substantiate (e.g., efficacy claims on the skin microflora).

In sum, can probiotics, prebiotics and postbiotics be considered cosmetic ingredients? Will they interfere with the microbiological limits set by regulators? Cosmetics containing these ‘ingredients’ fall under the definition of the EU Cosmetics Regulation or should be considered borderline products? There are still many questions to be answered and a case-by-case evaluation is usually advisable. CRITICAL CATALYST is here to help you! If you need further information or advice on which claims and type of substantiation can be made for your cosmetic products, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Commission Regulation (EU) No 655/2013 of 10 July 22013 laying down common criteria for the justification of claims used in relation to cosmetic products.
  3. Technical document on cosmetic claims. Agreed by the Sub-Working Group on Claims. 2017. European Commission.
  4. Microbiome and Cosmetics: Survey of Products, Ingredients, Terminologies and Regulatory Approaches. International Cooperation on Cosmetics Regulation (ICCR). 2021.

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »